Pharmaceutical industry – Page 13
-
OpinionVaccine development against the clock
How long will it take to develop a coronavirus vaccine and why is it so hard?
-
BusinessCan existing drugs slow Covid-19?
The fastest route to treatments may be to repurpose existing drugs – if they work
-
BusinessGetting ideas across
In a diverse industry like chemicals, we need to make sure we’re open to learning from unexpected angles.
-
OpinionTime for industry to show its humanity
Companies need to demonstrate community spirit in the face of the coronavirus pandemic
-
BusinessData is lacking as Reach moves beyond registration
Enforcing the demanding rules of Europe’s chemical legislation is keeping regulators and companies on their toes
-
OpinionWhy picking projects is like poker
Sometimes you prefer the high-risk, high-reward project to the ‘sure thing’
-
BusinessFDA freezes foreign facility inspections amid coronavirus pandemic
US regulator will rely on border checks and shared data, but some approval processes may be delayed
-
BusinessCoronavirus pandemic will disrupt international supply chains
Halted production and transport restrictions are straining industries that rely heavily on China for supplies
-
BusinessRNA vaccines are coronavirus frontrunners
Several groups have potential Sars-CoV-2 vaccines ready or close to testing, thanks to rapid development pathways
-
OpinionTwo heads are better than one
Bifunctionals show that sometimes simply tethering two useful molecules together unlocks some useful activity
-
NewsNumber of industrial chemicals being produced globally grossly underestimated
Analysis of national chemical inventories finds three times as many chemicals registered for production as previously thought
-
BusinessThe race to fight coronavirus
While genome sequences enable testing and vaccine efforts, companies are donating existing antiviral drugs to explore repurposing
-
ResearchWarning that 3D printing pills can stop drugs working
Photoreactive monomers need close scrutiny for production of polypills
-
BusinessCancer and rare diseases dominated 2019 drug approvals
More streamlined review processes and changing R&D priorities have contributed to sustained increase in new medicines
-
BusinessResearchers call for stricter rules on drug-like medical devices
More oversight is needed over products in the grey area between medical device and medication
-
OpinionStartup EQRx claims it can revolutionise drug discovery
If it can deliver reasonable drugs at knock-down prices, will providers be convinced?
-
OpinionReviewing performance reviews
Assessing the value of researchers’ work is hard, but there are some easy ideas to avoid
-
BusinessRevived Alzheimer’s antibody met with guarded optimism
Biogen’s aducanumab offers the possibility to slow disease progress, but regulators will likely want more convincing evidence
-
ResearchCompact pharmaceutical factory manufactures drugs on demand
Plant with modular design would occupy about half the area of a squash court
-
